一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (640k)
Article in Japanese

Case Report

Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: A case report

Susumu Sakamoto  Kyoko Gocho  Keita Satoh  Keishi Sugino  Kazutoshi Isobe  Sakae Homma 

Department of Respiratory Medicine, Toho University Omori Medical Center

ABSTRACT

A 73-year-old man was referred to our hospital in February 2009 for cough and dyspnea. A diagnosis of idiopathic pulmonary fibrosis was made on the basis of findings from chest computed tomography (CT) and a pulmonary function test (PFT). The patient was started on inhaled N-acetylcysteine in May 2009, and chest CT and PFT findings (+0.36 L; change in forced vital capacity [ΔFVC], +13.1%) had improved at 6 months. However, PFT and CT findings had worsened (-0.65 L; ΔFVC, -21%) at 17 months after starting inhaled N-acetylcysteine therapy, and pirfenidone treatment was added to inhaled NAC therapy in September 2010. CT and PFT findings (+0.47 L; ΔFVC, +19%) were markedly improved at 6 months after beginning combination therapy and remained at 36 months. This is the first report of successful treatment for disease progression of idiopathic pulmonary fibrosis with combination therapy comprising N-acetylcysteine and pirfenidone.

KEYWORDS

Idiopathic pulmonary fibrosis  N-Acetylcysteine  Pirfenidone  Combined therapy 

Received 13 Mar 2014 / Accepted 2 Jul 2014

AJRS, 3(5): 713-718, 2014

Google Scholar